Exploring Tai Chi and Qigong for Genital Herpes Management: Insights from Related Diseases Using Artificial Intelligence Volume 61- Issue 4

Robert W McGee*

• Fayetteville State University, USA

Received: April 19, 2025; Published: April 29, 2025

*Corresponding author: Robert W McGee, Fayetteville State University, USA

DOI: 10.26717/BJSTR.2025.61.009624

Abstract PDF

ABSTRACT

Background: Tai chi and qigong, traditional Chinese medicine practices, have been used for centuries to promote health and manage various conditions, yet no studies have explored their efficacy for genital herpes (herpes simplex virus type 2, HSV-2).
Objective: This exploratory study investigates the potential of tai chi and qigong as treatments for genital herpes by examining their effects on related diseases.
Methods: Using Grok 3, an artificial intelligence tool, we identified 10 diseases most closely related to genital herpes: oral herpes, neonatal herpes, herpes zoster, cytomegalovirus infection, human papillomavirus infection, syphilis, chancroid, lymphogranuloma venereum, eczema herpeticum, and HIV/AIDS. A PubMed search (2004– 2025) identified five studies on tai chi or qigong for two of these diseases (herpes zoster and HIV/AIDS). These studies were analyzed for sample demographics, treatment protocols, techniques, frequency, duration, and outcomes to extrapolate potential benefits for genital herpes.
Results: The studies (n=36–60 participants, primarily older adults, mixed genders, diverse ethnicities) used Tai Chi Chih, Yang-style tai chi, and qigong (Eight Brocades) in 1–1.5-hour sessions, 2–3 times weekly, for 8–15 weeks. Outcomes included enhanced shingles immunity, improved physical function, better quality of life, reduced depression, and trends toward lower inflammation in HIV patients, with no adverse events.
Conclusion: While direct evidence is absent, tai chi and qigong’s benefits for herpes zoster and HIV suggest potential for managing genital herpes symptoms, possibly via immune modulation and stress reduction. Further research is needed to test this hypothesis directly.

Keywords: Tai Chi; Qigong; Genital Herpes; Herpes Simplex Virus (HSV-2); Herpes Zoster; HIV/AIDS; Immune Function, Stress Reduction; Quality of Life; Artificial Intelligence; Sexually Transmitted Infections (STIs); Mind- Body Intervention; Complementary Medicine; Grok

Introduction

Tai chi and qigong, two ancient tools in the Traditional Chinese Medicine [TCM] toolbox, have been used to treat a wide variety of ailments for hundreds, or even thousands of years [1-13]. Although the main focus is on prevention rather than cure, many studies have found them to be effective as supplementary treatments as well. Some of the health benefits of practicing tai chi and qigong include:

• Improved balance and flexibility
• Stress reduction
• Better cardiovascular health
• Pain management
• Stronger immune function
• Enhanced mental clarity
• Increased energy

A nonexclusive list of the ailments they have been used to treat would include:

• Anxiety disorders [14-16]
• Asthma [17-21]
• Cancer (Supportive care) [22-39]
• Chronic back pain [40-44]
• Chronic fatigue syndrome [45-48]
• Chronic Obstructive Pulmonary Disease (COPD) [49-53]
• Dementia/Alzheimer’s [54-60]
• Depression [61-67]
• Diabetes (Type 2) [68-72]
• Fibromyalgia [73-77]
• Heart disease [78-83]
• Hypertension (high blood pressure) [84-89]
• Insomnia [90-94]
• Multiple Sclerosis [95-99]
• Osteoarthritis [100-104]
• Osteoporosis [105-109]
• Parkinson’s disease [110-114]
• Rheumatoid arthritis [115-119]
• Stroke recovery [120-124]
• Tension headaches [125-129]

The Study

The present study focuses on the use of tai chi and qigong to treat genital herpes. A search of the PubMed database [130] failed to find a single study where either tai chi or qigong had been used to treat genital herpes. That being the case, an attempt to extrapolate needed to be made. We asked Grok 3 [131], an artificial intelligence assistant, to make a list of the 10 diseases that were most like genital herpes. Artificial intelligence has been used with increasing frequency in medical research in recent years [132-148]. Its popularity and use are expected to grow as it becomes more sophisticated. We decided to give Grok 3 a try, since recent studies [149-151] have shown it to be both accurate and effective in medical research. Grok 3’s response is given below. To identify diseases closely related to herpes, we need to consider the characteristics of herpesviruses, particularly their virology, transmission, clinical manifestations, and associated conditions. The herpes family (Herpesviridae) includes viruses like herpes simplex virus (HSV-1 and HSV-2), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV), among others. “Related” diseases could mean those caused by other herpesviruses, those with similar symptoms or transmission modes, or conditions triggered or exacerbated by herpes infections. Below is a list of the 10 diseases most closely related to herpes, focusing primarily on herpesvirus- caused diseases, with a brief explanation of their connection.

1. Varicella (Chickenpox)

a. Caused by varicella-zoster virus (VZV), a herpesvirus. Like HSV, VZV establishes latency in nerve cells and shares similar skin lesion presentations. Both viruses are transmitted through direct contact or respiratory droplets.

2. Herpes Zoster (Shingles)

a. Also caused by VZV, this is a reactivation of latent virus, akin to HSV’s recurrent outbreaks. It presents with painful skin lesions, often in a dermatomal pattern, resembling severe herpes lesions.

3. Infectious Mononucleosis

a. Caused by Epstein-Barr virus (EBV), another herpesvirus. EBV, like HSV, is transmitted via bodily fluids (saliva) and can remain latent, with potential for reactivation. Both can cause systemic symptoms like fever and fatigue.

4. Cytomegalovirus Infection (CMV)

a. Caused by CMV, a herpesvirus. It shares HSV’s ability to cause asymptomatic infections, congenital disease, and severe illness in immunocompromised individuals. Transmission occurs through bodily fluids.

5. Kaposi’s Sarcoma

a. Associated with human herpesvirus 8 (HHV-8). Like HSV, HHV-8 can cause skin lesions and is linked to immunocompromised states (e.g., HIV/AIDS), where herpesviruses often exacerbate disease.

6. Roseola Infantum

a. Caused by human herpesvirus 6 (HHV-6) or 7 (HHV-7). These herpesviruses, like HSV, cause skin rashes and establish latency. Roseola’s fever and rash resemble milder herpes presentations.

7. Burkitt’s Lymphoma

a. Linked to EBV. While primarily a cancer, its herpesvirus association ties it to HSV, as both viruses can contribute to oncogenic processes under certain conditions (e.g., immunosuppression).

8. Nasopharyngeal Carcinoma

a. Another EBV-associated malignancy. Its relation to herpes stems from the shared herpesvirus family trait of latency and potential for triggering chronic diseases or cancers.

9. Bell’s Palsy

a. Sometimes associated with HSV or VZV reactivation. The neurological involvement and potential viral trigger mirror herpes’s neurotropism, where HSV can cause facial nerve inflammation.

10. Eczema Herpeticum

a. A complication of HSV infection in individuals with pre-existing skin conditions like eczema. It’s directly caused by HSV spreading across damaged skin, making it a close clinical relative.

Notes

• The list prioritizes diseases caused by herpesviruses (VZV, EBV, CMV, HHV-6, HHV-7, HHV-8) due to their virological and clinical overlap with HSV. Conditions like Bell’s palsy and eczema herpeticum are included for their direct or potential HSV association.

• Diseases like HPV-related infections or syphilis were considered but excluded, as they differ significantly in etiology (non-herpesvirus) despite some symptom overlap (e.g., genital lesions).

• If you meant “herpes” as specifically HSV-related genital or oral infections, let me know, and I can refine the list to focus on similar STDs or skin conditions. Would you like me to dig deeper into any of these?

Author Comments

Grok 3 provided an excellent starting point for further, deeper, more focused research. We asked it to dig deeper, and to focus on the kind of herpes that is sexually transmitted. Below are the results.

Grok 3 Reply: Since you’re particularly interested in sexually transmitted herpes, I’ll focus on herpes simplex virus type 2 (HSV- 2), which is primarily associated with genital herpes, though HSV-1 can also cause genital infections through sexual contact. I’ll refine the list of the 10 most closely related diseases, emphasizing conditions with similar transmission modes (sexual contact), clinical presentations (genital lesions, systemic symptoms), or virological connections within the herpesvirus family or other sexually transmitted infections (STIs). For each, I’ll provide a deeper exploration of their relationship to genital herpes, including epidemiology, pathophysiology, and clinical overlap, while keeping the explanations clear and concise. I’ll also integrate relevant insights from recent data or patterns where applicable.

Refined List of 10 Diseases Most Closely Related to Sexually Transmitted Herpes (Genital Herpes)

1. Oral Herpes (Cold Sores)

a. Cause: Primarily HSV-1, but increasingly HSV-2 due to oral-genital contact.

b. Connection: Shares the same virus (HSV) and transmission via mucosal contact. Genital herpes (HSV-2) can be transmitted to the mouth during oral sex, and vice versa, blurring the line between oral and genital infections. Both present with painful, vesicular lesions that recur due to viral latency in sensory ganglia.

c. Epidemiology: Globally, ~67% of people under 50 have HSV- 1, and ~13% have HSV-2 (WHO data). Rising HSV-1 genital cases reflect changing sexual practices.

d. Clinical Overlap: Lesions in both resolve in 7–14 days without treatment; antivirals (e.g., acyclovir) work for both. Latency and asymptomatic shedding increase transmission risk.

e. Why Related: Direct virological and transmission overlap, with shared triggers like stress or immunosuppression.

2. Neonatal Herpes

a. Cause: HSV-1 or HSV-2, typically acquired during vaginal delivery from a mother with genital herpes.

b. Connection: A severe consequence of genital herpes, where maternal HSV-2 shedding infects the newborn. It’s sexually transmitted in origin (from mother’s partner to mother), manifesting as disseminated infection, encephalitis, or skin/eye/mouth disease in the infant.

c. Epidemiology: Incidence is low (~10 per 100,000 births in the US) but devastating, with 60–80% mortality if untreated. d. Pathophysiology: HSV’s neurotropism leads to central nervous system damage in neonates, mirroring genital herpes’s nerve latency.

e. Why Related: Direct complication of genital herpes, highlighting its reproductive health impact. Cesarean delivery reduces risk if active lesions are present.

3. Herpes Zoster (Shingles)

a. Cause: Varicella-zoster virus (VZV), a herpesvirus.

b. Connection: While not sexually transmitted, VZV’s latency and reactivation parallel HSV-2’s behavior. Shingles can rarely affect genital areas, mimicking genital herpes lesions, and both viruses respond to similar antivirals.

c. Clinical Overlap: Painful, unilateral lesions (shingles) versus bilateral genital sores (herpes), but both involve nerve reactivation. VZV can theoretically be transmitted via lesion contact, though it’s less common than HSV’s sexual spread.

d. Epidemiology: Shingles affects ~1 in 3 people lifetime, mostly older adults or immunocompromised, unlike genital herpes’s broader age range.

e. Why Related: Shared herpesvirus family traits (latency, neurotropism) and occasional genital presentation.

4. Cytomegalovirus Infection (CMV)

a. Cause: Cytomegalovirus, a herpesvirus.

b. Connection: CMV can be sexually transmitted via bodily fluids (semen, vaginal secretions), like HSV-2. Both cause asymptomatic or mild infections in healthy adults but are severe in immunocompromised individuals or fetuses.

c. Pathophysiology: CMV establishes latency in mononuclear cells, while HSV-2 targets neurons, but both evade immune clearance. CMV’s genital shedding mirrors HSV-2’s asymptomatic shedding.

d. Epidemiology: ~50–80% of adults are CMV-seropositive; sexual transmission is a key route in high-risk groups (e.g., MSM).

e. Why Related: Shared herpesvirus latency and sexual transmission, with similar risks in pregnancy (congenital infection).

5. Human Papillomavirus Infection (HPV)

a. Cause: HPV, a non-herpesvirus DNA virus.

b. Connection: HPV is a sexually transmitted infection causing genital warts or asymptomatic infection, often co-occurring with genital herpes due to shared risk factors (multiple partners, unprotected sex). Both can lead to recurrent lesions or oncogenic outcomes (HPV: cervical cancer; HSV-2: debated cancer link).

c. Clinical Overlap: HPV’s warts differ from HSV’s ulcers, but misdiagnosis occurs due to genital localization. Co-infection increases HIV acquisition risk.

d. Epidemiology: HPV is the most common STI (~79 million US cases); HSV-2 affects ~12% of US adults.

e. Why Related: Shared sexual transmission and genital tropism, with overlapping public health implications.

6. Syphilis

a. Cause: Treponema pallidum, a spirochete bacterium.

b. Connection: Syphilis, an STI, causes genital chancres in its primary stage, which can be confused with herpes sores. Both increase HIV transmission risk and share sexual contact as a primary route.

c. Pathophysiology: Syphilis lesions are painless, unlike HSV’s painful ulcers, but both involve mucosal breaks facilitating co-infections.

d. Epidemiology: Syphilis rates are rising (~133,945 US cases in 2023); HSV-2 prevalence is higher but stable.

e. Why Related: Clinical mimicry and shared STI profile, requiring differential diagnosis in genital ulcer cases.

7. Chancroid

a. Cause: Haemophilus ducreyi, a bacterium.

b. Connection: A sexually transmitted cause of genital ulcers, chancroid resembles genital herpes in presentation (painful sores) and transmission. Co-infection is common in high-risk settings.

c. Clinical Overlap: Chancroid’s soft, purulent ulcers contrast with HSV’s vesicles, but both cause lymphadenopathy and require lab testing to distinguish.

d. Epidemiology: Rare in developed countries (<100 US cases annually) but prevalent in resource-limited settings where HSV-2 is also common.

e. Why Related: Shared STI route and genital ulcer syndrome, often co-tested in clinical protocols.

8. Lymphogranuloma Venereum (LGV)

a. Cause: Chlamydia trachomatis (serotypes L1–L3).

b. Connection: LGV, an STI, causes genital ulcers or proctitis, particularly in MSM, overlapping with genital herpes’s demographics and transmission. Both persist in mucosal tissues.

c. Pathophysiology: LGV’s invasive nature contrasts with HSV’s epithelial focus, but both trigger immune responses increasing STI susceptibility.

d. Epidemiology: LGV is uncommon but rising in MSM populations; HSV-2 affects broader groups but shares risk behaviors.

e. Why Related: Sexual transmission and genital/rectal pathology, with diagnostic overlap in ulcerogenic STIs.

9. Eczema Herpeticum

a. Cause: HSV-1 or HSV-2 complicating pre-existing skin conditions (e.g., eczema).

b. Connection: A direct HSV complication, where genital herpes virus spreads across damaged skin, causing severe, disseminated lesions. Sexual transmission of HSV-2 can initiate the primary infection.

c. Clinical Overlap: Painful, crusted lesions mimic genital herpes outbreaks but are more widespread. Immunosuppression (e.g., HIV) increases risk.

d. Epidemiology: Rare but significant in atopic dermatitis patients; genital herpes is a common entry point.

e. Why Related: Direct HSV etiology, with genital herpes as a potential trigger.

10. HIV/AIDS

a. Cause: Human immunodeficiency virus.

b. Connection: HIV and HSV-2 are sexually transmitted and synergistically worsen outcomes. HSV-2 increases HIV acquisition risk 2–3-fold by creating mucosal entry points, and HIV accelerates HSV-2 shedding and severity.

c. Pathophysiology: HSV-2’s immune activation (CD4+ cell recruitment) facilitates HIV infection; HIV’s immunosuppression triggers frequent HSV-2 recurrences.

d. Epidemiology: ~38 million people live with HIV globally; HSV-2 co-infection is near-universal in HIV-positive STI patients.

e. Why Related: Shared sexual transmission and profound epidemiological/ clinical interaction.

Deeper Insights

• Virological Context: Genital herpes (HSV-2) is a double- stranded DNA virus with lifelong latency in dorsal root ganglia, reactivating under stress, hormonal changes, or immune suppression. Other herpesviruses (CMV, VZV, EBV) share this latency trait, but only CMV has significant sexual transmission, making it a closer relative than EBV or HHV-6 for this focus.

• Transmission Dynamics: HSV-2 spreads via skin-to-skin contact, especially during asymptomatic shedding (~20% of days in infected individuals). This mirrors HPV, HIV, and syphilis, which exploit mucosal breaches, unlike respiratory- spread herpesviruses (e.g., VZV).

• Clinical Challenges: Genital herpes’s painful vesicles/ulcers overlap with chancroid, syphilis, and LGV, necessitating PCR or serology for diagnosis. Misdiagnosis delays treatment, increasing transmission. Co-infections (e.g., HSV-2 + HIV) complicate management due to drug interactions and immune compromise.

• Public Health: HSV-2’s global prevalence (~520 million cases) underscores its STI burden, second only to HPV. Vaccines exist for HPV and are in trials for HSV-2, but none for other listed diseases except VZV (shingles vaccine). Condom use reduces risk for all listed STIs, though less effectively for HSV- 2 due to shedding beyond covered areas.

• Emerging Trends: Recent data (2023–2025) show rising STI rates, including syphilis and LGV, in MSM communities, where HSV-2 co-infection is common. HSV-1’s growing role in genital herpes (~30–50% of new cases in some regions) reflects oral sex prevalence, tying oral and genital herpes closer together.

Notes

• I prioritized STIs (HPV, syphilis, chancroid, LGV, HIV) for their shared transmission and clinical overlap with genital herpes, alongside herpesvirus diseases (CMV, zoster, neonatal herpes) for virological ties. Eczema herpeticum and oral herpes are direct HSV manifestations.

• Excluded diseases like gonorrhea or trichomoniasis lack ulcerative pathology, reducing their similarity to HSV-2’s presentation.

• If you want more on a specific disease (e.g., HIV-HSV interactions, vaccine prospects), treatment options, or prevention strategies, let me know! Would you like me to explore any angle further or provide visuals (e.g., a chart comparing these diseases)?

Author Comments

Grok 3 provided excellent expanded information on the 10 most closely-related diseases and offered to explore a number of different angles. We decided to accept the offer to provide a chart comparing the 10 diseases. That chart is reproduced below.

Grok 3 Reply: To address your request, I’ll create a chart comparing the 10 diseases most closely related to sexually transmitted herpes (genital herpes, primarily caused by HSV-2, with some HSV-1 cases), as listed in my previous response: Oral Herpes, Neonatal Herpes, Herpes Zoster, Cytomegalovirus Infection (CMV), Human Papillomavirus Infection (HPV), Syphilis, Chancroid, Lymphogranuloma Venereum (LGV), Eczema Herpeticum, and HIV/AIDS. The chart will compare these diseases across key characteristics relevant to their relationship with genital herpes, ensuring clarity and utility. Since you’ve asked for a chart and my capabilities include visualizing basic charts, I’ll describe a tabular format with concise data, focusing on Cause, Transmission, Primary Symptoms, Treatment, and Prevalence. If you prefer a graphical chart (e.g., bar or radar), let me know, and I can suggest how to proceed.

Notes on Chart Design

• Columns Explained:

• Cause: Identifies the pathogen (virus, bacterium) and its relation to herpesviruses (HSV is a herpesvirus; VZV and CMV are too, unlike others).

• Transmission: Highlights sexual contact for most, aligning with genital herpes’s primary route, with nuances (e.g., zoster’s non-sexual spread).

• Primary Symptoms: Focuses on genital or skin manifestations to show overlap (e.g., ulcers in syphilis, chancroid) or differences (e.g., zoster’s unilateral rash).

• Treatment: Lists standard therapies, noting antivirals for herpesviruses versus antibiotics for bacterial STIs.

• Prevalence: Provides global or regional estimates (where available) to contextualize disease burden, using WHO, CDC, or UNAIDS data up to 2025.

• Why This Format: A table allows side-by-side comparison across multiple diseases and criteria, making it easy to spot similarities (e.g., sexual transmission in HPV, syphilis) and differences (e.g., zoster’s non-STI nature). Numbers are approximate due to varying data sources and underreporting.

• Limitations: Prevalence data vary by region and year; exact figures for rare diseases (e.g., LGV, chancroid) are less precise. Symptoms listed are primary but not exhaustive (e.g., HIV’s chronic phase is simplified).

Key Observations

• Virological Ties: Genital herpes, oral herpes, neonatal herpes, zoster, CMV, and eczema herpeticum are herpesvirus-related, sharing latency and antiviral treatments. Others (HPV, syphilis, chancroid, LGV, HIV) are STIs with clinical overlap (genital lesions or immune interactions).

• Transmission: Most diseases (except zoster) are sexually transmitted, aligning with genital herpes’s epidemiology. Neonatal herpes and eczema herpeticum stem directly from HSV exposure.

• Symptoms: Genital ulcers link herpes, syphilis, chancroid, and LGV; HPV’s warts and zoster’s rash differ but affect skin. HIV’s systemic effects contrast with herpes’s localized outbreaks but synergize (HSV increases HIV risk).

• Treatment: Antivirals dominate for herpesviruses; antibiotics treat bacterial STIs. HPV and HIV require unique approaches (vaccines, ART).

• Prevalence: HPV and oral herpes are more common than genital herpes; neonatal herpes and chancroid are rare. HIV and HSV-2 co-infection is significant in STI populations.

Additional Context

• Why Compare These? The chart highlights diseases that either share HSV’s virology (herpesviruses like CMV, VZV), mimic its genital presentation (syphilis, chancroid), or amplify its impact (HIV). This aids differential diagnosis and underscores public health overlaps.

• Visual Alternative: If you’d like a graphical chart (e.g., comparing prevalence or symptom severity), I can describe one (e.g., bar chart of global cases) or suggest data for you to visualize elsewhere, as I can’t render images directly. Would you prefer that?

• Further Details: If you want deeper analysis (e.g., diagnostic challenges, co-infection rates), I can expand on any row or column. For example, HSV-HIV synergy increases transmission risk 2–3-fold, per recent studies. Let me know if you’d like me to refine the chart (e.g., add columns like Complications or Diagnosis), generate a mock dataset for visualization, or focus on specific diseases for more detail!

Author Comments

Grok 3 provided an excellent comparative analysis. We decided to ask it to provide a mock dataset, which is reproduced below in Chart 1.

Grok 3 Reply: Below is the dataset, using approximate global prevalence estimates based on WHO, CDC, UNAIDS, and other data up to 2025. Numbers are rounded for simplicity and reflect active cases or seropositivity where relevant (e.g., CMV’s high seroprevalence includes latent cases, like herpesviruses).

Author Comments

Chart 1 provided a good summary of the prevalence of the 10 most closely related diseases. The next step was to find studies that had been conducted using either tai chi or qigong to treat each of the 10 most closely related diseases. A summary of the findings is given below in Table 1. A search of the PubMed database for studies published between 2004-2025 produced the following results. The search found only four tai chi studies [152-155] and two qigong studies [154,156] for any of the ten most closely related diseases. However, one of the studies was cited for both the tai chi and qigong categories, the result being that only five studies examined the use of either tai chi or qigong in the treatment of the 10 most closely related diseases Chart 2. The next step was to examine the studies to determine some of the specifics, such as which disease was treated, how it was treated, which specific tai chi or qigong techniques were used, how were they used, and what were the results. If any of these studies produced positive results, one might extrapolate to tentatively conclude that using similar techniques might be effective in treating genital herpes (HSV- 2). Grok 3 was asked to summarize the five studies separately Table 2. The summaries were to include the size and demographics of each sample, which disease was treated, how it was treated, which tai chi or qigong techniques were used, how frequently and for what period, and the outcomes. It was also asked to summarize the five summaries in a table, which it did. The results are reported below.

Grok 3 Reply: Below are summaries of the five studies, addressing the requested details: sample size and demographics, disease treated, treatment approach, tai chi or qigong techniques used, frequency and duration, and outcomes. After the summaries, I’ll provide a table consolidating the information.

1. Irwin, et al. [152]

Study: Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment.

• Sample Size and Demographics:

• 36 elderly adults (aged 60+ years, mean age ~70), both men and women, from the Los Angeles area. Participants were healthy or had a history of varicella-zoster virus (VZV) infection.

• Disease Treated:

• Shingles (herpes zoster) immunity, specifically targeting varicella-zoster virus-specific responder cell frequency (VZVRCF), and health functioning in the elderly.

• Treatment Approach:

• Randomized controlled trial comparing Tai Chi Chih (TCC) to a wait-list control group.

• Tai Chi/Qigong Techniques Used:

• Tai Chi Chih, a simplified form of tai chi with 20 standardized movements focusing on meditative and slow-motion exercises.

• Frequency and Duration:

• 1-hour sessions, 3 times per week, for 15 weeks.

• Outcomes:

o Significant increase in VZV-RCF in the TCC group compared to controls (p < 0.05).

o Improved physical functioning (measured by SF-36 scale) in the TCC group, particularly in physical role and vitality subscales.

2. Galantino, et al. [153]

Study: The Effect of Group Aerobic Exercise and T’ai Chi on Functional Outcomes and Quality of Life for Persons Living with Acquired Immunodeficiency Syndrome.

• Sample Size and Demographics:

38 adults (mean age 42 years, 76% male, 24% female, predominantly African American and Hispanic) diagnosed with AIDS (CD4 counts <200 cells/mm³), recruited from Philadelphia.

• Disease Treated:

Acquired Immunodeficiency Syndrome (AIDS), focusing on functional outcomes and quality of life.

• Treatment Approach:

Randomized controlled trial with three groups: tai chi, aerobic exercise, and a no-exercise control group.

• Tai Chi/Qigong Techniques Used:

Yang-style tai chi, emphasizing slow, flowing movements with mindfulness and breathing coordination.

• Frequency and Duration:

1-hour sessions, twice per week, for 8 weeks.

• Outcomes:

o Tai chi group showed improved functional outcomes (e.g., balance and mobility) compared to controls (p < 0.05).

o Quality of life (measured by MOS-HIV scale) improved in both tai chi and aerobic groups, but tai chi had a greater effect on physical function.

o No significant changes in immune parameters (CD4 counts).

o High adherence in the tai chi group (80% attendance).

3. Ibañez, et al. [154]

Study: A Tai Chi/Qigong Intervention for Older Adults Living with HIV: A Study Protocol of an Exploratory Clinical Trial.

• Sample Size and Demographics:

Planned sample of 60 older adults (aged 50+ years) living with HIV, both genders, from South Florida. (Note: This is a protocol, so actual participant demographics are not reported.)

• Disease Treated:

HIV, targeting physical and mental health outcomes, including inflammation, physical function, and quality of life.

• Treatment Approach:

Planned randomized controlled trial with two arms: tai chi/qigong intervention versus a wait-list control group.

• Tai Chi/Qigong Techniques Used:

Combined tai chi and qigong program, including Yang-style tai chi forms (short form) and qigong exercises (e.g., Eight Brocades) focusing on breathing, meditation, and gentle movements.

• Frequency and Duration:

90-minute sessions, twice per week, for 12 weeks.

• Outcomes:

o As a protocol, no outcomes are reported. Expected outcomes include:

o Improved physical function (e.g., 6-minute walk test).

o Reduced inflammation (e.g., IL-6, CRP levels).

o Enhanced quality of life and mental health (e.g., depression scales).

4. Zhang, et al. [155]

Study: Exercise for Neuropathic Pain: A Systematic Review and Expert Consensus.

• Sample Size and Demographics:

Systematic review, not a primary study, so no specific sample. Included studies involved adults (18+ years, both genders) with neuropathic pain from various causes (e.g., diabetic neuropathy, postherpetic neuralgia). Demographics varied across studies.

• Disease Treated:

Neuropathic pain (chronic pain due to nerve damage).

• Treatment Approach:

Reviewed multiple exercise interventions, including tai chi, compared to controls (no exercise or standard care).

• Tai Chi/Qigong Techniques Used:

Tai chi (specific styles not detailed in all studies, but Yang style commonly referenced), focusing on slow movements, balance, and relaxation.

• Frequency and Duration:

Varied across studies, typically 30–60-minute sessions, 1–3 times per week, for 8–12 weeks.

• Outcomes:

o Tai chi reduced neuropathic pain intensity (effect size moderate, p < 0.05 in meta-analyses).

o Improved physical function (e.g., balance, mobility) and quality of life.

o Benefits were more consistent with longer interventions (>8 weeks).

o No adverse events reported for tai chi.

5. Ibañez, et al. [156]

Study: Acceptability and Feasibility of a Tai Chi/Qigong Intervention for Older People Living With HIV.

• Sample Size and Demographics:

52 older adults (mean age 59 years, 73% male, 27% female, 60% African American, 30% Hispanic, 10% White) living with HIV, recruited from South Florida.

• Disease Treated:

HIV, focusing on acceptability, feasibility, and preliminary health outcomes (e.g., physical function, mental health).

• Treatment Approach:

Pilot randomized controlled trial comparing tai chi/qigong to a wait-list control group.

• Tai Chi/Qigong Techniques Used:

Combined tai chi (Yang-style short form) and qigong (Eight Brocades, meditation, and breathing exercises).

• Frequency and Duration:

90-minute sessions, twice per week, for 12 weeks.

• Outcomes:

o High acceptability (85% rated the intervention as enjoyable).

o Feasibility confirmed (78% attendance rate, no dropouts due to intervention).

o Preliminary outcomes: improved physical function (6-minute walk test, p < 0.05), reduced depression scores (p < 0.05), and trends toward lower inflammation markers (not statistically significant). o No adverse events reported.

Notes

• The Ibañez et al. (2020) study is a protocol, so outcomes are anticipated rather than observed.

• Zhang et al. (2021) is a systematic review, so sample and intervention details are aggregated across studies.

• All studies reported positive or neutral outcomes with no significant adverse events.

Concluding Comments

This exploratory study represents a novel attempt to bridge a gap in the literature by examining the potential of tai chi and qigong as interventions for genital herpes, a condition for which no direct studies exist. By leveraging artificial intelligence (Grok 3) to identify diseases closely related to genital herpes and analyzing five relevant studies on herpes zoster and HIV/AIDS, we found consistent evidence of tai chi and qigong’s benefits, including improved immune function, physical performance, mental health, and quality of life. These outcomes, observed across diverse populations and intervention protocols, suggest plausible mechanisms—such as stress reduction, immune modulation, and enhanced physical resilience—that could translate to genital herpes management. Notably, the absence of adverse events underscores the safety of these practices, making them promising candidates for further exploration. However, the reliance on extrapolation limits definitive conclusions. Genital herpes, while sharing virological and clinical features with diseases like herpes zoster and HIV, presents unique challenges, including recurrent outbreaks and psychosocial impacts, which require targeted investigation. The small number of relevant studies and the heterogeneity of their designs further caution against overgeneralization. Future research should prioritize randomized controlled trials specifically for genital herpes, exploring tai chi and qigong’s effects on outbreak frequency, symptom severity, and immunological markers like HSV-2 shedding. Incorporating patient-reported outcomes, such as stigma and emotional well-being, could also enhance the holistic understanding of these interventions. This study lays the groundwork for such efforts, highlighting the potential of traditional Chinese medicine to complement conventional treatments for sexually transmitted infections.

Funding

None.

Conflict of Interest

None.

References

1. Frantzis Bruce (2010) Dragon and Tiger Medical Qigong, North Atlantic Books 1.
2. Jahnke Roger (1997) The Healer Within. Harper Collins.
3. Jahnke, Roger (2002) The Healing Power of Qi. Contemporary Books.
4. Lin, Chunyi (2005) Born a Healer. Spring Forest Publishing.
5. Liu, Tianjun (2013) Chinese Medical Qigong. Singing Dragon.
6. McGee, Robert W (2025) The Health Benefits of Tai Chi & Qigong. New York: Prime Publishing.
7. McGee Robert W (2025) Incorporating Tai Chi & Qigong into a Medical Practice. New York: Prime Publishing.
8. McGee Robert W (2021) Tai Chi, Qigong and the Treatment of Disease. Biomedical Journal of Scientific & Technical Research 34(2): 26627-26633.
9. McGee Robert W (2021) The Use of Yi Jin Jing to Treat Illness: A Summary of Three Studies. Academia Letters, Article 547.
10. McGee Robert W (2022) Qigong and the Treatment of Illness: Recent Case Studies. Biomedical Journal of Scientific & Technical Research 43(1): 34250-35253.
11. McGee Robert W (2023) Some Beneficial Health Effects of Tai Chi and Qigong. Biomedical Journal of Scientific & Technical Research 52(3): 43813-43817.
12. McGee Robert W (2023) Recent Studies in Traditional Chinese Medicine (TCM), Biomedical Journal of Scientific & Technical Research 50(4): 41817-41820.
13. Xu, Xiangcai (2000) Qigong for Treating Common Ailments. YMAA Publication Center.
14. Li Z, Liu S, Wang L, Smith L (2019) Mind-Body Exercise for Anxiety and Depression in COPD Patients: A Systematic Review and Meta-Analysis. International journal of environmental research and public health 17(1): 22.
15. Liu F, Cui J, Liu X, Chen K W, Chen X, et al. (2020) The effect of tai chi and Qigong exercise on depression and anxiety of individuals with substance use disorders: a systematic review and meta-analysis. BMC complementary medicine and therapies 20(1): 161.
16. McGee Robert W (2021) Tai Chi, Qigong and the Treatment of Depression and Anxiety. Biomedical Journal of Scientific & Technical Research 36(2): 28350-28354.
17. Heredia Rizo AM, Martinez Calderon J, Piña-Pozo F, González García P, García Muñoz C, et al. (2024) Effectiveness of mind-body exercises in chronic respiratory diseases: an overview of systematic reviews with meta-analyses. Disabil Rehabil 46(12): 2496-2511.
18. Liao PC, Lin HH, Chiang BL, Lee JH, Yu HH, et al. (2019) Tai Chi Chuan Exercise Improves Lung Function and Asthma Control through Immune Regulation in Childhood Asthma. Evid Based Complement Alternat Med 23: 9146827.
19. Lin HC, Lin HP, Yu HH, Wang LC, Lee JH, et al. (2017) Tai-Chi-Chuan Exercise Improves Pulmonary Function and Decreases Exhaled Nitric Oxide Level in Both Asthmatic and Nonasthmatic Children and Improves Quality of Life in Children with Asthma. Evid Based Complement Alternat Med, pp. 6287642.
20. Lorenc AB, Wang Y, Madge SL, Hu X, Mian AM, et al. (2014) Robinson N. Meditative movement for respiratory function: a systematic review. Respir Care 59(3): 427-440.
21. Pretorius E (2009) The role of alternative and complementary treatments of asthma. Acupunct Electrother Res 34(1-2): 15-26.
22. Arring N M, Barton D L, Brooks T, Zick S M (2019) Integrative Therapies for Cancer-Related Fatigue. Cancer journal (Sudbury, Mass.) 25(5): 349-356.
23. Campbell K L, Zadravec K, Bland K A, Chesley E, Wolf F, et al. (2020) The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials. Physical therapy, 100(3): 523-542.
24. Chang P S, Knobf T (2019) Qigong Exercise and Tai Chi in Cancer Care. Asia-Pacific journal of oncology nursing 6(4): 315-317.
25. Cheng T C, Lee Y H, Mar C L, Huang W T, Chang Y P, et al (2020) The Health Promoting Mindfulness or Qigong Educational Programs for Beneficial Lifestyle Changes of Cancer Survivors. Journal of cancer education: the official journal of the American Association for Cancer Education 35(4): 743-750.
26. Garland S N, Mahon K, Irwin M R (2019) Integrative Approaches for Sleep Health in Cancer Survivors. Cancer journal (Sudbury, Mass.) 25(5): 337-342.
27. Kinney AY, Blair CK, Guest DD, Ani JK, Harding EM, et al. (2019) Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial. Contemporary clinical trials communications 16: 100431.
28. Kreutz C, Schmidt ME, Steindorf K (2019) Effects of physical and mind-body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis. Breast cancer research and treatment 176(1): 1-15.
29. Larkey L, Kim W, James D, Kishida M, Vizcaino M, et al. (2020) Mind-Body and Psychosocial Interventions May Similarly Affect Heart Rate Variability Patterns in Cancer Recovery: Implications for a Mechanism of Symptom Improvement. Integrative cancer therapies 19: 1534735420949677.
30. McGee, Robert W (2021) Tai Chi, Qigong and the Treatment of Cancer. Biomedical Journal of Scientific & Technical Research, 34(5): 27173-27182.
31. McGee Robert W (2022) Using Tai Chi and Qigong to Treat Cancer Symptoms. Biomedical Journal of Scientific & Technical Research 45(2): 36333-36336.
32. McGee Robert W (2022) Traditional Chinese Medicine and the Treatment of Cancer. Biomedical Journal of Scientific & Technical Research 47(4): 38636-38639.
33. McGee Robert W (2024) Tai Chi, Qigong and the Treatment of Breast Cancer. Biomedical Journal of Scientific & Technical Research 54(3): 46024-46027.
34. McGee Robert W (2024) Tai Chi, Qigong and the Treatment of Lung Cancer: A Study in Artificial Intelligence. Biomedical Journal of Scientific & Technical Research 55(4): 47220-47225.
35. McGee Robert W (2024) Using Chinese Herbal Medicine to Treat Cancer Patients: A Study Incorporating Artificial Intelligence. Biomedical Journal of Scientific & Technical Research 56(5): 48647-48655.
36. McGee Robert W (2024) Utilizing Tai Chi and Qigong to Treat Colon Cancer Survivors. Biomedical Journal of Scientific & Technical Research 58(5): 51017-51025.
37. McGee Robert W (2020) Qigong and the Treatment and Prevention of Cancer. Fayetteville State University, Broadwell College of Business and Economics, Studies in the Economics of Qigong, p. 7.
38. McGee Robert W (2025) Qigong and the Treatment and Prevention of Cancer (Updated), Fayetteville State University, Broadwell College of Business and Economics, Studies in the Economics of Qigong 9.
39. McGee Robert W (2025) Utilizing Tai Chi & Qigong to Treat Cancer Survivors. New York: Prime Publishing.
40. Chen X, Cui J, Li R, Norton R, Park J, et al. (2019) Dao Yin (a.k.a. Qigong): Origin, Development, Potential Mechanisms, and Clinical Applications. Evidence-based complementary and alternative medicine.
41. McGee Robert W (2024) Using Artificial Intelligence, Tai Chi and Qigong to Treat Ankylosing Spondylitis. Biomedical Journal of Scientific & Technical Research 57(5): 49823-49831.
42. Park J, Krause Parello C A, Barnes C M (2020) A Narrative Review of Movement-Based Mind-Body Interventions: Effects of Yoga, Tai Chi, and Qigong for Back Pain Patients. Holistic nursing practice 34(1): 3-23.
43. Tang S K, Tse M, Leung S F, Fotis T (2019) The effectiveness, suitability, and sustainability of non-pharmacological methods of managing pain in community-dwelling older adults: a systematic review. BMC public health 19(1): 1488.
44. Zou L, Zhang Y, Yang L, Loprinzi P D, Yeung A S, et al. (2019) Are Mindful Exercises Safe and Beneficial for Treating Chronic Lower Back Pain? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of clinical medicine 8(5): 628.
45. Alraek T, Lee MS, Choi TY, Cao H, Liu J (2011) Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review. BMC Complement Altern Med 11: 87.
46. Kong L, Ren J, Fang S, Li Y, Wu Z, et al. (2023) Effects of traditional Chinese mind-body exercises for patients with chronic fatigue syndrome: A systematic review and meta-analysis. J Glob Health 13: 04157.
47. Wu K, Li Y, Zou Y, Ren Y, Wang Y, et al. (2022) Tai Chi increases functional connectivity and decreases chronic fatigue syndrome: A pilot intervention study with machine learning and fMRI analysis. PLoS One 17(12): e0278415.
48. Xie F, Guan C, Cheng Z, Yao F, You Y (2020) Effects of the prolong life with nine turn method (Yan Nian Jiu Zhuan) Qigong on patients with chronic fatigue syndrome: study protocol for a randomized controlled trial. Annals of palliative medicine 9(5): 3571-3583.
49. Li Z, Liu S, Wang L, Smith L (2019) Mind-Body Exercise for Anxiety and Depression in COPD Patients: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 17(1): 22.
50. Liu W, Liu XM, Huang YL, Yu PM, Zhang XW, et al. (2023) Tai Chi as a complementary exercise for pulmonary rehabilitation in chronic obstructive pulmonary disease: A randomised controlled trial. Complement Ther Med 78: 102977.
51. Ngai SP, Jones AY, Tam WW (2016) Tai Chi for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2016(6): CD009953.
52. Nolan CM, Rochester CL (2019) Exercise Training Modalities for People with Chronic Obstructive Pulmonary Disease. COPD 16(5-6): 378-389.
53. Yang L, Zhong D, Zhang Y, Li Y, Liu T, et al. (2021) Tai Chi for Chronic Obstructive Pulmonary Disease (COPD): An Overview of Systematic Reviews. Int J Gen Med 14: 3017-3033.
54. Chan J, Deng K, Wu J, Yan J H (2019) Effects of Meditation and Mind-Body Exercises on Older Adults' Cognitive Performance: A Meta-analysis. The Gerontologist 59(6): e782-e790.
55. Jiayuan Z, Xiang Zi J, Li Na M, Jin Wei Y, Xue Y (2022) Effects of Mindfulness-Based Tai Chi Chuan on Physical Performance and Cognitive Function among Cognitive Frailty Older Adults: A Six-Month Follow-Up of a Randomized Controlled Trial. J Prev Alzheimers Dis 9(1): 104-112.
56. Li B, Tang H, He G, Jin Z, He Y, et al. (2023) Tai Chi enhances cognitive training effects on delaying cognitive decline in mild cognitive impairment. Alzheimers Dement 19(1): 136-149.
57. McGee Robert W (2021) Ba Duan Jin and the Treatment of Illness in General, and Cognitive Impairment in Particular. Biomedical Journal of Scientific & Technical Research 40(2): 32058-32065.
58. McGee Robert W (2023) Tai Chi, Qigong and the Treatment of Dementia, Biomedical Journal of Scientific & Technical Research 53(5): 45080-45085.
59. Wayne PM, Walsh JN, Taylor Piliae RE, Wells RE, Papp KV, et al. (2014) Effect of tai chi on cognitive performance in older adults: systematic review and meta-analysis. J Am Geriatr Soc 62(1): 25-39.
60. Zou L, Loprinzi P D, Yeung A S, Zeng N, Huang T (2019) The Beneficial Effects of Mind-Body Exercises for People With Mild Cognitive Impairment: a Systematic Review With Meta-analysis. Archives of physical medicine and rehabilitation 100(8): 1556-1573.
61. Gill BK, Cant R, Lam L, Cooper S, Lou V, et al. (2020) non-pharmacological depression therapies for older Chinese adults: A systematic review & meta-analysis. Archives of gerontology and geriatrics 88: 104037.
62. Gouw V, Jiang Y, Seah B, He H, Hong J, et al. (2019) Effectiveness of internal Qigong on quality of life, depressive symptoms and self-efficacy among community-dwelling older adults with chronic disease: A systematic review and meta-analysis. International journal of nursing studies 99: 103378.
63. Henshall CL, Allin L, Aveyard H (2019) A Systematic Review and Narrative Synthesis to Explore the Effectiveness of Exercise-Based Interventions in Improving Fatigue, Dyspnea, and Depression in Lung Cancer Survivors. Cancer nursing 42(4): 295-306.
64. Lee P, Cai S, Lu EY, Ng B, Jensen MP, et al. (2020) Qigong Reduces Depressive Symptoms of Taiwanese Elderly with Chronic Physical Illness: A Randomized Controlled Trial. Journal of alternative and complementary medicine (New York, N.Y.) 26(1): 76-78.
65. McGee Robert W (2021) Tai Chi, Qigong and the Treatment of Depression and Anxiety. Biomedical Journal of Scientific & Technical Research 36(2): 28350-28354.
66. So WWY, Cai S, Yau SY, Tsang HWH (2019) The Neurophysiological and Psychological Mechanisms of Qigong as a Treatment for Depression: A Systematic Review and Meta-Analysis. Front Psychiatry 10: 820.
67. Zaprutko T, Göder R, Rybakowski F, Kus K, Kopciuch D, et al. (2020) Non-pharmacological treatments of inpatients with major depression - The case of Polish (Poznan) and German (Kiel) hospital. Complementary therapies in clinical practice 39: 101129.
68. Chao M, Wang C, Dong X, Ding M (2018) The Effects of Tai Chi on Type 2 Diabetes Mellitus: A Meta-Analysis. J Diabetes Res 2018: 7350567.
69. Chen Y, Qin J, Tao L, Liu Z, Huang J, et al. (2023) Effects of Tai Chi Chuan on Cognitive Function in Adults 60 Years or Older with Type 2 Diabetes and Mild Cognitive Impairment in China: A Randomized Clinical Trial. JAMA Netw Open 6(4): e237004.
70. Hamasaki H (2024) Effects of Tai Chi in diabetes patients: Insights from recent research. World J Diabetes 15(1): 1-10.
71. Li X, Si H, Chen Y, Li S, Yin N, et al. (2020) Effects of fitness qigong and tai chi on middle-aged and elderly patients with type 2 diabetes mellitus. PLoS One 15(12): e0243989.
72. Setiyorini E, Qomaruddin MB, Wibisono S, Juwariah T, Setyowati A, et al. (2022) Complementary and alternative medicine for glycemic control of diabetes mellitus: A systematic review. J Public Health Res 11(3): 22799036221106582.
73. Bravo C, Skjaerven LH, Guitard Sein Echaluce L, Catalan Matamoros D (2019) Effectiveness of movement and body awareness therapies in patients with fibromyalgia: a systematic review and meta-analysis. Eur J Phys Rehabil Med 55(5): 646-657.
74. Busch AJ, Webber SC, Brachaniec M, Bidonde J, Bello-Haas VD, et al. (2011) Exercise therapy for fibromyalgia. Curr Pain Headache Rep 15(5): 358-67.
75. Liu X, Seah J, Pang B, Tsao MA, Gu F, et al. (2020) A single-arm feasibility study of community-delivered Baduanjin (Qigong practice of the eight Brocades) training for frail older adults. Pilot and feasibility studies 6: 105.
76. Sawynok J (2018) Benefits of Tai Chi for fibromyalgia. Pain Manag 8(4): 247-250.
77. Wang C, Schmid CH, Fielding RA, Harvey WF, Reid KF, et al. (2018) Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial. BMJ 360: k851.
78. Chen X, Cui J, Li R, Norton R, Park J, et al. (2019) Dao Yin (a.k.a. Qigong): Origin, Development, Potential Mechanisms, and Clinical Applications. Evidence-based complementary and alternative medicine 3705120.
79. Dalusung Angosta A (2011) The impact of Tai Chi exercise on coronary heart disease: a systematic review. J Am Acad Nurse Pract 23(7): 376-381.
80. Gomes Neto M, Durães AR, Conceição LSR, Saquetto MB, Alves IG, et al. (2024) Some types of exercise interventions are more effective than others in people with coronary heart disease: systematic review and network meta-analysis. J Physiother 70(2): 106-114.
81. Mao S, Zhang X, Chen M, Wang C, Chen Q, et al. (2020) Beneficial Effects of Baduanjin Exercise on Left Ventricular Remodelling in Patients after Acute Myocardial Infarction: an Exploratory Clinical Trial and Proteomic Analysis. Cardiovascular drugs and therapy 35(1): 21-32.
82. McGee Robert W (2024) Using Tai Chi, Qigong and Chinese Herbs to Reduce Cholesterol: A Study Incorporating Artificial Intelligence. Biomedical Journal of Scientific & Technical Research 57(1): 48776-48784.
83. Ng SM, Wang CW, Ho RT, Ziea TC, He J, et al. (2012) Tai chi exercise for patients with heart disease: a systematic review of controlled clinical trials. Altern Ther Health Med 18(3): 16-22.
84. Korsager Larsen M, Matchkov VV (2016) Hypertension and physical exercise: The role of oxidative stress. Medicina (Kaunas). 52(1): 19-27.
85. Li X, Chang P, Wu M, Jiang Y, Gao Y, et al. (2024) Effect of Tai Chi vs Aerobic Exercise on Blood Pressure in Patients With Prehypertension: A Randomized Clinical Trial. JAMA Netw Open 7(2): e2354937.
86. Liu D, Yi L, Sheng M, Wang G, Zou Y, et al. (2020) The Efficacy of Tai Chi and Qigong Exercises on Blood Pressure and Blood Levels of Nitric Oxide and Endothelin-1 in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based complementary and alternative medicine, pp. 3267971.
87. McGee Robert W (2021) Tai Chi, Qigong and the Treatment of Hypertension. Biomedical Journal of Scientific & Technical Research 39(1): 31055-31062.
88. Park JE, Yang CS, Jung SY, Kim AR, Lee M, et al. (2019) Exploring the effects of expert-led qigong and self-practice qigong on blood pressure. Integrative medicine research 8(4): 271-272.
89. Zhang W, Wang H, Xiong Z, Li C (2024) Efficacy of Tai Chi exercise in patients with hypertension: systematic review and meta-analysis. Curr Probl Cardiol 49(11): 102798.
90. Dong X, Zhang R, Guo Y, Chen L, Liu Y, et al. (2020) The efficacy of Qigong exercises for post-stroke mental disorders and sleep disorders: Protocol for a systematic review and meta-analysis. Medicine 99(34): e21784.
91. Hasan F, Tu YK, Lin CM, Chuang LP, Jeng C, et al. (2022) Comparative efficacy of exercise regimens on sleep quality in older adults: A systematic review and network meta-analysis. Sleep Med Rev 65: 101673.
92. Siu PM, Yu AP, Tam BT, Chin EC, Yu DS, et al. (2021) Effects of Tai Chi or Exercise on Sleep in Older Adults With Insomnia: A Randomized Clinical Trial. JAMA Netw Open 4(2): e2037199.
93. Wang S, Lan Y, Liu Z, Xu S, Wu X, et al. (2023) Effects of different interventions on insomnia in adults: Systematic review and network meta-analysis. J Psychiatr Res 165: 140-149.
94. Yu DJ, Yu AP, Li SX, Chan RNY, Fong DY, et al. (2023) Effects of Tai Chi and cognitive behavioral therapy for insomnia on improving sleep in older adults: Study protocol for a non-inferiority trial. J Exerc Sci Fit 21(1): 67-73.
95. Charron S, McKay KA, Tremlett H (2018) Physical activity and disability outcomes in multiple sclerosis: A systematic review (2011-2016). Mult Scler Relat Disord 20: 169-177.
96. McGee Robert W (2025) Tai Chi, Qigong and Their Use in Neuroscience. Biomedical Journal of Scientific & Technical Research 60(2): 52416-52418.
97. McGee Robert W (2025) Using Artificial Intelligence to Conduct Medical Research on Applications of Tai Chi and Qigong: A Case Study of Multiple Sclerosis. Biomedical Journal of Scientific & Technical Research 61(2): 53398-53402.
98. Taylor E, Taylor-Piliae RE (2017) The effects of Tai Chi on physical and psychosocial function among persons with multiple sclerosis: A systematic review. Complement Ther Med 31: 100-108.
99. Zou L, Wang H, Xiao Z, Fang Q, Zhang M, et al. (2017) Tai chi for health benefits in patients with multiple sclerosis: A systematic review. PLoS One 12(2): e0170212.
100. Chen X, Cui J, Li R, Norton R, Park J, et al. (2019) Dao Yin (a.k.a. Qigong): Origin, Development, Potential Mechanisms, and Clinical Applications. Evidence-based complementary and alternative medicine: eCAM, pp. 3705120.
101. McGee Robert W (2021) Tai Chi, Qigong and the Treatment of Arthritis. Biomedical Journal of Scientific & Technical Research 37(5): 29724-29734.
102. McGee Robert W (2024) Using Tai Chi to Treat Osteoarthritis and Osteoporosis of the Knee: A Bibliography.
103. Marks R (2019) Qigong and Musculoskeletal Pain. Current rheumatology reports, 21(11): 59.
104. Xie Y, Guo F, Lu Y, Guo Y, Wei G, et al. (2019) A 12-week Baduanjin Qigong exercise improves symptoms of ankylosing spondylitis: A randomized controlled trial. Complementary therapies in clinical practice 36: 113-119.
105. Li J, Guo J, Wang X, Zhang X, Zhang Y, et al. (2023) Efficacy and safety of tai chi exercise on bone health: An umbrella review. Osteoporos Int 34(11): 1853-1866.
106. Liu M, Liu D, Hong P, Qiu X, Chen Q, et al. (2020) The effect of Qigong Wuqinxi for osteopenia and primary osteoporosis: A protocol for systematic review and meta analysis. Medicine 99(21): e20379.
107. McGee Robert W (2024) Using Tai Chi to Treat Osteoarthritis and Osteoporosis of the Knee: A Bibliography.
108. Zhang Y, Chai Y, Pan X, Shen H, Wei X, et al. (2019) Tai chi for treating osteopenia and primary osteoporosis: a meta-analysis and trial sequential analysis. Clin Interv Aging 14: 91-104.
109. Zhang Y, Chen H (2024) Effect of Tai Chi exercise on bone health and fall prevention in postmenopausal women: a meta-analysis. J Orthop Surg Res 19(1): 471.
110. Chen S, Zhang Y, Wang Y T, Liu, Song W, et al. (2020) The effect of Qigong-based therapy on patients with Parkinson's disease: a systematic review and meta-analysis. Clinical rehabilitation.
111. Fidan O, Seyyar G K, Aras B, Colak E, Aras O, et al. (2019) The effect of Tai Chi and Qigong on health-related quality of life in Parkinson's disease: a systematic review and meta-analysis of systematic reviews. International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation 42(3): 196-204.
112. Jin X, Wang L, Liu S, Zhu L, Loprinzi PD, et al. (2019) The Impact of Mind-body Exercises on Motor Function, Depressive Symptoms, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-analysis. International journal of environmental research and public health 17(1): 31.
113. Li G, Huang P, Cui SS, Tan YY, He YC, et al. (2022) Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson's disease patients. Transl Neurodegener 11(1): 6.
114. Moon S, Sarmento C, Steinbacher M, Smirnova I V, Colgrove Y, et al. (2020) Can Qigong improve non-motor symptoms in people with Parkinson's disease - A pilot randomized controlled trial?. Complementary therapies in clinical practice 39: 101169.
115. Akyuz G, Kenis Coskun O (2018) The Efficacy of Tai Chi and Yoga in Rheumatoid Arthritis and Spondyloarthropathies: A narrative biomedical review. Rheumatol Int 38(3): 321-330.
116. Han A, Robinson V, Judd M, Taixiang W, Wells G, et al. (2004) Tai chi for treating rheumatoid arthritis. Cochrane Database Syst Rev (3): CD004849.
117. Marks R (2019) Qigong and Musculoskeletal Pain. Current rheumatology reports 21(11): 59.
118. Mudano AS, Tugwell P, Wells GA, Singh JA (2019) Tai Chi for rheumatoid arthritis. Cochrane Database Syst Rev 9(9): CD004849.
119. Negrini F (2021) Is Tai Chi beneficial for rheumatoid arthritis?-A Cochrane Review summary with commentary. Int J Rheum Dis 24(6): 855-857.
120. Chen C H, Hung K S, Chung Y C, Yeh ML (2019) Mind-body interactive qigong improves physical and mental aspects of quality of life in inpatients with stroke: A randomized control study. European journal of cardiovascular nursing: journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 18(8): 658-666.
121. Dong X, Zhang R, Guo Y, Chen L, Liu Y, et al. (2020) The efficacy of Qigong exercises for post-stroke mental disorders and sleep disorders: Protocol for a systematic review and meta-analysis. Medicine 99(34): e21784.
122. Wang C, Yu L, Yang J, Wang R W, Zheng Y N, et al. (2020) Effectiveness of LiuZiJue Qigong versus traditional core stability training for poststroke patients complicated with abnormal trunk postural control: study protocol for a single-center randomized controlled trial. Trials 21(1): 254.
123. Zhao J, Chau JPC, Chan AWK, Meng Q, et al. (2022) Tailored Sitting Tai Chi Program for Subacute Stroke Survivors: A Randomized Controlled Trial. Stroke 53(7): 2192-2203.
124. Zheng Y, Zhang Y, Li H, Qiao L, Fu W, et al. (2020) Comparative effect of Liuzijue Qigong and conventional respiratory training on trunk control ability and respiratory muscle function in patients at an early recovery stage from stroke: a randomized controlled trial. Archives of physical medicine and rehabilitation.
125. Abbott RB, Hui KK, Hays RD, Li MD, Pan T (2007) A randomized controlled trial of tai chi for tension headaches. Evid Based Complement Alternat Med 4(1): 107-113.
126. Ha WS, Chu MK (2024) Advances in Exercise in the Clinical Trials of Migraine: A Scoping Review. Curr Pain Headache Rep 28(8): 753-767.
127. Wells RE, Beuthin J, Granetzke L (2019) Complementary and Integrative Medicine for Episodic Migraine: An Update of Evidence from the Last 3 Years. Curr Pain Headache Rep 23(2): 10.
128. Xie YJ, Tian L, Hui SS, Qin J, Gao Y, et al. (2022) Efficacy and feasibility of a 12-week Tai Chi training for the prophylaxis of episodic migraine in Hong Kong Chinese women: A randomized controlled trial. Front Public Health 10: 1000594.
129. Xie YJ, Liao X, Hui SS, Tian L, Yeung WF, et al. (2023) Tai Chi for the prophylaxis of episodic migraine: protocol of a non-inferiority randomized controlled trial with mechanism exploration. BMC Complement Med Ther 23(1): 328.
130. PubMed Database
131. Grok 3
132. Adrián P Hunis (2024) The Role of Artificial Intelligence in Oncology: Transforming Cancer Diagnosis and Treatment. Biomed J Sci & Tech Res 57(3).
133. Bellido Casado J, Dufrechou Negreira E, Munizio Mello FF (2024) Problem Decision Making in Healthcare: Human Decision or Artificial Intelligence Decision. Biomed J Sci & Tech Res 57(4).
134. Benjamin Wu, Yucheng Liu, Meng Jou Wu, Hiram Shaish, Hong Yun Ma (2024) Usage of Artificial Intelligence in Gallbladder Segmentation to Diagnose Acute Cholecystitis. A Case Report. Biomed J Sci & Tech Res 55(2).
135. Purohit Saraswati, Suneel Kumar C N (2024) AI in Health Care: A Comprehensive Review. Biomed J Sci & Tech Res 57(4).
136. Marcos A M Almeida, Matheus H C de Araujo (2023) The Use of Artificial Intelligence in the Classification of Medical Images of Brain Tumors. Biomed J Sci & Tech Res 53(4).
137. Philippe Funk (2023) Biomedical Computation Artificial Intelligence Challenges in Cloud Environments. Biomed J Sci & Tech Res 50(4).
138. Angela Hsu, Robin Zachariah, James Han, William Karnes (2023 Artificial Intelligence for Colonoscopy: Beyond Polyp Detection – A Review of where we are Today and where AI can Take us. Biomed J Sci & Tech Res 49(3).
139. Jyoti Lamba, Taniya Malhotra, Drishti Palwankar, Vrinda Vats, Akshat Sachdeva (2023) Artificial Intelligence in Dentistry: A Literature Review. Biomed J Sci & Tech Res 51(1).
140. Michael L Carty, Stephane Bilodeau (2023) Artificial Intelligence and Medical Oxygen. Biomed J Sci & Tech Res 51(2).
141. M Ablameyko, N Shakel (2022) Doctor-Patient-Artificial Intelligence Relations in Smart Healthcare. Biomed J Sci & Tech Res 44(5).
142. Hergan Klaus, Zinterhof Peter, Abed Selim, et al. (2022) Challenges implementing and running an AI-Lab: Experience and Literature Review. Biomed J Sci & Tech Res 45(4).
143. Sotiris Raptis, Christos Ilioudis, Vasiliki Softa, Kiki Theodorou (2022) Artificial Intelligence in Predicting Treatment Response in Non-Small-Cell Lung Cancer (NSCLC). Biomed J Sci & Tech Res 47(3).
144. Omar Sayyouh (2022) Machine Learning Application to Combat Superbugs in Hospitals: A Primer to Infection Prevention Practitioners. Biomed J Sci & Tech Res 44(5).
145. Sotiris Raptis, Christos Ilioudis, Vasiliki Softa, Kiki Theodorou (2022) Artificial Intelligence in Predicting Treatment Response in Non-Small-Cell Lung Cancer (NSCLC). Biomed J Sci & Tech Res 47(3).
146. Ahmed Asfari (2021) Artificial Intelligence Role and Clinical Decision Support System Extubation Readiness Trail and Etiometry Scoring System. Biomed J Sci & Tech Res 35(1).
147. Ik Whan G Kwon, Sung Ho Kim (2021) Digital Transformation in Healthcare. Biomed J Sci & Tech Res 34(5).
148. Luca Marzi, Fabio Vittadello, Alessandra Andreotti, Andrea Piccin, Andrea Mega (2021) Will Artificial Intelligence Unveil Hepatocellular Carcinoma?. Biomed J Sci & Tech Res 35(4).
149. McGee Robert W (2025) What is Bafa Wubu Tai Chi, and Is It a More Effective Medical Technique than the Yang 24 Form? A Preliminary Study. Biomedical Journal of Scientific & Technical Research 61(1): 53139-53148.
150. McGee Robert W (2025) Using Artificial Intelligence to Conduct Medical Research on Applications of Tai Chi and Qigong: A Case Study of Multiple Sclerosis. Biomedical Journal of Scientific & Technical Research 61(2): 53398-53402.
151. Researching Qigong, Tai Chi, Yoga, and Mindfulness for College Students’ Mental Health. American Journal of Biomedical Science & Research 26(4): 584-598.
152. Irwin M, Pike J, Oxman M (2004) Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment. Evid Based Complement Alternat Med Dec 1(3): 223-232.
153. Galantino ML, Shepard K, Krafft L, Laperriere A, Ducette J, et al. (2005) The effect of group aerobic exercise and t'ai chi on functional outcomes and quality of life for persons living with acquired immunodeficiency syndrome. J Altern Complement Med Dec 11(6): 1085-1092.
154. Ibañez GE, Fennie K, Larkey L, Hu N, Algarin AB, et al. (2020) A tai chi/qigong intervention for older adults living with HIV: a study protocol of an exploratory clinical trial. Trials 21(1): 804.
155. Zhang YH, Hu HY, Xiong YC, Peng C, Hu L, et al. (2021) Exercise for Neuropathic Pain: A Systematic Review and Expert Consensus. Front Med (Lausanne) 8: 756940.
156. Ibañez GE, Ahmed S, Hu N, Larkey L, Fennie KP, et al. (2024) Acceptability and Feasibility of a Tai Chi/Qigong Intervention for Older People Living With HIV. AIDS Behav 28(4): 1291-1300.